FDA recall, , Moderate risk
Rhode Island Blood Center Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor who had traveled to an area endemic for malaria.
Recall ended Jun 23, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Rhode Island Blood Center, A Division of New York Blood Center, Inc., recalled Red Blood Cells, Leukocytes Reduced because the cells were collected from a donor who had traveled to an area designated as endemic for malaria. The recall began April 4, 2025, and the FDA added it to its Enforcement Report on June 23, 2026. The product was distributed in Connecticut.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Rhode Island Blood Center, A Division of New York Blood Center, Inc.
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99010
- Recall number
- B-0079-2026
All recalls from Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
